Results for tag: "Hypoparathyroidism Drug"

Hypoparathyroidism is a rare endocrine disorder caused by a deficiency of parathyroid hormone. Treatment for this disorder typically involves the use of drugs to replace the missing hormone and to control calcium levels. Common drugs used to treat hypoparathyroidism include calcitriol, paricalcitol, and cinacalcet. These drugs are used to regulate calcium levels, reduce the risk of bone fractures, and reduce the risk of complications from the disorder. The hypoparathyroidism drug market is a small but growing segment of the endocrine and metabolic disorders drugs market. This market is driven by the increasing prevalence of hypoparathyroidism, the development of new drugs, and the increasing awareness of the disorder. Some of the major companies in the hypoparathyroidism drug market include AbbVie, Amgen, Eli Lilly, Merck, Novartis, and Pfizer. These companies are involved in the development, manufacture, and marketing of drugs for the treatment of hypoparathyroidism. Show Less Read more